Dutch Building Stock News

InPost (ENXTAM:INPST) released its third quarter earnings and reported sales growth to PLN 3,768.9 million. Net income dipped to PLN 170.7 million compared to the same period last year. See our latest analysis for InPost. After reporting strong revenue growth but sliding net income, InPost’s share price momentum has continued to cool off. The stock currently trades at €10.05, with a year-to-date share price return of -39.78%. Over the past twelve months, total shareholder return stands at...

Arcadis (ENXTAM:ARCAD) shares are drawing attention after posting a dip of 2% at the last close. The recent performance highlights continued pressure over the past month and raises questions for investors about the stock’s underlying value. See our latest analysis for Arcadis. After a sharp 24.3% drop in the 1-month share price return, Arcadis has seen selling pressure intensify, pulling its year-to-date share price return down nearly 40%. The 1-year total shareholder return is now at -43.8%,...

Wolters Kluwer (ENXTAM:WKL) stock recently caught the attention of investors looking at its performance over the past month. Shares have experienced a steady drop, while the company has reported modest revenue and net income growth for the year. The company’s valuation now invites fresh review. See our latest analysis for Wolters Kluwer. After a tough stretch, Wolters Kluwer's share price has dropped more than 40% year-to-date. This momentum has clearly faded compared to previous years of...

On November 6, 2025, Pharming Group N.V. reported strong quarterly earnings with nine-month sales of US$269.6 million, up from US$204.53 million the previous year, and raised its full-year 2025 revenue guidance to between US$365 million and US$375 million. A key development was the company's announcement that the FDA granted priority review for leniolisib's potential pediatric label expansion, signaling further growth opportunities for its rare disease portfolio. With robust revenue momentum...

Ever wondered if Prosus could be your next smart investment? Let’s pull back the curtain on its true value and see if the current price stacks up to reality. After a standout year with gains of 53.9%, Prosus’ shares have seen some recent volatility, dipping 1.6% in the past week and 5.5% over the past month. However, they remain up an impressive 52.7% year-to-date. Behind these moves, market watchers are eyeing news like Prosus’s continued tech investments and portfolio reshuffling, as well...

Coca-Cola Europacific Partners PLC ( AMS:CCEP ) has announced that it will be increasing its periodic dividend on the...

Pharming Group (ENXTAM:PHARM) caught investors’ attention after raising its revenue outlook for 2025, now forecasting up to USD 375 million. This move follows impressive year-over-year sales growth and a significantly smaller net loss. See our latest analysis for Pharming Group. Pharming Group’s upbeat revenue guidance and narrowing net loss have clearly caught the market’s attention, with the share price leaping over 24% in a day and posting a remarkable 42.5% year-to-date gain. Over the...

With a price-to-earnings (or "P/E") ratio of 18.8x Aalberts N.V. ( AMS:AALB ) may be sending bearish signals at the...

ArcelorMittal (ENXTAM:MT) has seen solid movement in its stock price in recent months, catching the interest of investors looking at trends in the steel sector. The company’s overall performance invites a closer look at its valuation and prospects. See our latest analysis for ArcelorMittal. ArcelorMittal’s share price has charged up an impressive 47.85% so far this year, with the recent 15.48% three-month return giving investors plenty to talk about. Momentum seems to be building again, which...

AMG Critical Materials (ENXTAM:AMG) posted a strong set of headline numbers, with earnings forecast to grow 39.9% per year, well ahead of the Dutch market’s 11.2% growth rate. Revenue, meanwhile, is expected to rise 4.7% annually, trailing the broader market’s 7.8%. The company has recently returned to profitability and has grown earnings by 7.4% per year over the past five years.

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Koninklijke Philips (ENXTAM:PHIA) just reported that its revenue is forecast to grow at 4.2% per year, trailing behind the broader Dutch market’s expected 7.8% yearly pace. After averaging a sharp 34.8% annual earnings decline over the last five years, the company has flipped back to profitability this year, though a one-off loss of €446 million in the past 12 months put a notable dent in recent results. Now, analysts are betting on earnings to jump by 35.19% per year, with profit growth set...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Heineken (ENXTAM:HEIA) shares have shown modest movement over the past month, trading at around €68.44. Investors are weighing recent performance alongside the company’s solid annual revenue and net income growth as the outlook for the beverage sector evolves. See our latest analysis for Heineken. Heineken’s 1-month share price return of 3.7% hints at improved sentiment as investors look past a tough 12 months, where the total shareholder return is still down 5.2%. Momentum appears to be...

Wondering if Wolters Kluwer’s stock offers real value right now? You’re not alone. Let’s dig into what the numbers and recent shifts actually mean for investors. Despite a strong run over the past five years (up 57.8%), shares have slipped by 3.3% in the last week and are now down 33.6% year-to-date, suggesting sentiment and risk perception may be changing. Much of this movement has been driven by broader market volatility and sector rotation among European professional services stocks...

DSM-Firmenich (ENXTAM:DSFIR) is set to present at the upcoming Partnership Opportunities in Drug Delivery (PODD) conference in Boston. Investors are watching closely, interested in potential updates on innovative drug delivery technologies. See our latest analysis for DSM-Firmenich. DSM-Firmenich’s scheduled appearance at PODD comes after a tough run for investors, with the 1-year total shareholder return sliding 33.9%. Recent momentum has faded, and shares sit at €69.8, reflecting a 28%...

Wondering whether Adyen’s current stock price offers real value, or if you could be overpaying? You’re definitely not alone in that curiosity. In the past year, Adyen’s stock has edged up only 3.0%, and it has hardly moved this month. This hints at shifting investor sentiment and new questions around growth and risk. Headlines have focused on Adyen’s continued expansion into new markets and partnerships with major retailers. This has sparked fresh debate around the future of digital payments...

Koninklijke Ahold Delhaize's (AMS:AD) stock is up by 3.5% over the past month. We wonder if and what role the company's...

Koninklijke Philips (ENXTAM:PHIA) has seen its share price hold steady recently, with investors looking over the company’s latest financial results and ongoing business performance. Philips continues to generate discussion regarding its earnings and market position. See our latest analysis for Koninklijke Philips. Philips’ share price has been rangebound so far this year, reflecting mixed investor sentiment following recent results and last year's volatility. While the year-to-date share...

Wondering if JDE Peet's stock is a great deal right now? You are not alone, especially as more investors are eyeing its recent moves. This year, the stock has surged an impressive 89%, and it is up 64.7% over the past 12 months, suggesting the market may be rethinking its growth and risk profile. Recent headlines have highlighted JDE Peet’s push to expand its global coffee presence and efforts to strengthen its sustainability commitments. Both developments have captured investor interest and...

Universal Music Group (ENXTAM:UMG) and AI music startup Udio have settled a copyright dispute and are teaming up to create a new AI-powered music platform in 2026. This collaboration signals a shift for UMG toward integrating advanced technology solutions in music creation. See our latest analysis for Universal Music Group. Following the news of Universal Music Group’s AI partnership, shares have seen some volatility, with a 6.8% slide over the past month but a modest 1.2% gain in total...

Flow Traders (ENXTAM:FLOW) released its third-quarter results, falling short of market expectations as weak revenue capture and lower net trading income weighed on profits. The company also closed $275 million in new credit facilities to support future initiatives. See our latest analysis for Flow Traders. Shares in Flow Traders have struggled to build momentum lately, sliding 6.7% after the Q3 miss and now down more than 8% over the past month. While the 1-year total shareholder return is...

On October 30, 2025, DSM-Firmenich reported solid third-quarter growth, a significant increase in Adjusted EBITDA, and provided updates on its ongoing €1 billion share repurchase program and the planned exit from its Animal Nutrition & Health business, with the divestment on track to conclude in the fourth quarter. The company also revised its full-year outlook due to unfavorable foreign exchange effects and continued volatility in vitamins, reflecting the operational challenges of its...

In late October 2025, Arcadis N.V. repurchased 61,852 of its own shares as part of its recently announced capital reduction program, bringing total buybacks under this initiative to 448,008 shares to date. The company also reported a return to organic growth in Q3 2025, achieving €936 million in net revenues and an operating EBITA margin expansion to 11.6%, driven by portfolio shifts toward energy, water, climate, and technology markets with strong demand in North America and Europe. To...